In recent years, many more innovative medicines have become available for people whose arthritis has not responded well enough to first-line treatments. These synthetic and biological DMARDs are more ...

“The initial treatments are the same for both,” says Bauer, noting that tumor necrosis factor (TNF) inhibitors work well for both types of arthritis, especially for people who can’t take methotrexate, ...

Ankylosing spondylitis is the type of arthritis ... for treatment of ankylosing spondylitis has been non-steroidal anti-inflammatory agents. So when these patients are first seen, along with ...

In this review, recent changes in both treatments and outcomes of rheumatoid arthritis (RA ... to control RA disease activity more tightly. In line with this, the outcomes of patients with ...

what treatments to consider next, and how to prevent further progression and damage. The Rheumatoid Arthritis Severity Scale (RASS) was developed in the early 2000s to help doctors determine ...

ice first. Can I use topical agents that I have at home? The answer is sure. And you have many of those. But remember, any of those are very short-living activities. What about other treatment ...

Persistent pain is common in rheumatoid arthritis. But patient-reported outcomes tools can help clinicians determine a care plan.

Recovery from knee replacement surgery and other surgical treatments for knee arthritis can be long and arduous. During the first and second months, your condition may feel worse before it gets ...

Patients with the most common form of arthritis will have access to a ... offering patients a non-invasive and effective second line treatment option to improve their quality of life,” Martin ...

My journey with juvenile arthritis began before I can remember. When I first began to walk ... which isn't exactly a treatment plan for an autoimmune disease. That flare finally sent me into ...

Panelists discuss how the introduction of adjuvant immunotherapy has influenced their first-line treatment decisions for ...

Several treatment alternatives have been investigated, such as intraperitoneal chemotherapy, alternative doublets and triplet regimens, in the effort to find an optimal first-line treatment strategy.